Search research articles
Contact Us
Filters
Showing results (241-250 of 270) with videos related to
Page
of 27
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
Peng Hou, Haiming Chen, Sihao Liang, et al.
Frontiers in Pharmacology
|
February 7, 2022
The Gene Expression Analysis of Peripheral Blood Monocytes From Psoriasis Vulgaris Patients With Different Traditional Chinese Medicine Syndromes
Yue Lu, Yao Qi, Li Li, et al.
Hematological Oncology
|
August 31, 2022
The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma
Ning Xu, Erin Yu, Nicole Ng, et al.
International Journal of Oncology
|
June 28, 2014
Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance
Sara Huerta-Yepez, Hong Liu, Stavroula Baritaki, et al.
European Radiology
|
June 4, 2024
The diagnostic value of [<sup>18</sup>F]FAPI-42 PET/CT for pulmonary artery masses: comparison with [<sup>18</sup>F]FDG PET/CT
Peng Hou, Kaixiang Zhong, Wenliang Guo, et al.
International Journal of Oncology
|
May 11, 2006
LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma
Richard A Campbell, Steven J Manyak, Honghao H Yang, et al.
Annals of Hematology
|
January 13, 2019
The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo
Eric Sanchez, Mingjie Li, Saurabh Patil, et al.
British Journal of Haematology
|
May 10, 2006
Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status
Howard S Yeh, Haiming Chen, Steven J Manyak, et al.
British Journal of Haematology
|
April 23, 2020
Estimating a normal reference range for serum B-cell maturation antigen levels for multiple myeloma patients
Scott Jew, Sean Bujarski, Camilia Soof, et al.
Drug Design, Development and Therapy
|
June 19, 2024
The Benefit of the Optimized Formula of Yinxieling in Psoriasis Vulgaris via Regulation on Autophagy Based on microRNA Expression Profile and Network Pharmacology Analysis
Yue Lu, Simin Pan, Wenzhen Li, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 270) with videos related to
Sort By:
Page
of 27
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 3, 2025
Targeting Fibroblast Activation Protein for Molecular Imaging of Fibrotic Remodeling in Pulmonary Arterial Hypertension
Peng Hou, Haiming Chen, Sihao Liang, et al.
Frontiers in Pharmacology
|
February 7, 2022
The Gene Expression Analysis of Peripheral Blood Monocytes From Psoriasis Vulgaris Patients With Different Traditional Chinese Medicine Syndromes
Yue Lu, Yao Qi, Li Li, et al.
Hematological Oncology
|
August 31, 2022
The JAK1/2 inhibitor ruxolitinib downregulates the immune checkpoint protein B7H3 in multiple myeloma
Ning Xu, Erin Yu, Nicole Ng, et al.
International Journal of Oncology
|
June 28, 2014
Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance
Sara Huerta-Yepez, Hong Liu, Stavroula Baritaki, et al.
European Radiology
|
June 4, 2024
The diagnostic value of [<sup>18</sup>F]FAPI-42 PET/CT for pulmonary artery masses: comparison with [<sup>18</sup>F]FDG PET/CT
Peng Hou, Kaixiang Zhong, Wenliang Guo, et al.
International Journal of Oncology
|
May 11, 2006
LAGlambda-1: a clinically relevant drug resistant human multiple myeloma tumor murine model that enables rapid evaluation of treatments for multiple myeloma
Richard A Campbell, Steven J Manyak, Honghao H Yang, et al.
Annals of Hematology
|
January 13, 2019
The anti-myeloma effects of the selective JAK1 inhibitor (INCB052793) alone and in combination in vitro and in vivo
Eric Sanchez, Mingjie Li, Saurabh Patil, et al.
British Journal of Haematology
|
May 10, 2006
Serum pleiotrophin levels are elevated in multiple myeloma patients and correlate with disease status
Howard S Yeh, Haiming Chen, Steven J Manyak, et al.
British Journal of Haematology
|
April 23, 2020
Estimating a normal reference range for serum B-cell maturation antigen levels for multiple myeloma patients
Scott Jew, Sean Bujarski, Camilia Soof, et al.
Drug Design, Development and Therapy
|
June 19, 2024
The Benefit of the Optimized Formula of Yinxieling in Psoriasis Vulgaris via Regulation on Autophagy Based on microRNA Expression Profile and Network Pharmacology Analysis
Yue Lu, Simin Pan, Wenzhen Li, et al.
Page
of 27